fah hospital policy blog

The so-called Medicare buy-in for those over 50 would harm more Americans than it would help. That is why we strongly oppose this legislation.

The DC Federal District Court’s ruling to stop reforms to Medicare payment for drugs acquired under the 340B drug discount program is unfortunate because it undermines HHS efforts to cut drug costs and promote fairer payments.

Today, FAH submitted comments in response to a Proposed Rule from the Centers for Medicare & Medicaid Services (CMS) making changes to the Medicare Advantage (MA) program. The FAH letter addressed support for the following policies:

The Federation of American Hospitals joined 16 other groups in sending a letter to Congressional leaders today urging them to preserve the actions taken in the Bipartisan Budget Act (BBA) of 2018 to protect seniors and taxpayers from out-of-control drug prices during the upcoming lame duck session of Congress.